4Di Marco V,Di Stefano R,Ferraro D,et al.HBV DNA suppression and disease course in HBV cirrhosis patients on long-term lamivudine therapy.Antivir Ther.2005,10(3):431-439.
6Choi WB,Suh DJ,Kim SH,et al.Adefovir diPivoxil alone or in combination with lamivudine in patients with lamivudine resistant decompensated liver disease.(abstract).Korean J Hepatol,2004,10:S103.
7Marcellin P,Lau GK,Bonino F,et al.Peginterferon alfa-2a alone,lamivudine alone,and the two in combination in patients with HBeAg-negative chronic hepatitis B.N Engl J Med,2004,351(12):1206-1217.
8Lau GK,Piratvisuth T,Luo KX,et al.Peginterferon alfa-2a,lamivudine,and the combination for HBeAg-positive chronic hepatitis B.N Engl J Med,2005,352(26):2682-2695.
7Moon W, Choi MS, Moon YM.Efficacy and safety of adefovir dipivoxil in patients with decompensated liver cirrhosis with lamivudine resistance compared to patients with compensated liver disease[J].Korean J Hepatol, 2005, 11 (2):125.
8Westland CE, Yang H, Delaney WE, et al.Activity of adefovir dipivoxil against all patterns of lamivudine-resistant hepatitis B viruses in patients[J]. J Viral Hepat, 2005,12( 1 ) : 67.
